Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingxia Fan

Showing results (41-50 of 107) with videos related to

Pageof 11
Sort By:
Oncology Reports|September 2, 2014
Assessment of insulin-like growth factor 1 receptor as an oncogene in esophageal squamous cell carcinoma and its potential implication in chemotherapyWang Ma, Tengfei Zhang, Jian Pan, et al.
Cell Biochemistry and Biophysics|February 26, 2011
Antitumor activity of a combination of rAd2p53 adenoviral gene therapy and radiotherapy in esophageal carcinomaPing Lu, Xiaoyu Yang, Yanmei Huang, et al.
International Journal of Oncology|May 17, 2018
MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathwayYan Zhao, Ke Ma, Shujun Yang, et al.
Biochemical and Biophysical Research Communications|June 27, 2019
Retraction notice to "miR-4295 promotes cell proliferation and invasion in anaplastic thyroid carcinoma via CDKN1A" [Biochem. Biophys. Res. Commun. 464/4 (2015) 1309-1313]Mingchen Shao, Yiwei Geng, Peng Lu, et al.
Biochemical and Biophysical Research Communications|August 2, 2015
miR-4295 promotes cell proliferation and invasion in anaplastic thyroid carcinoma via CDKN1AMingchen Shao, Yiwei Geng, Peng Lu, et al.
Nanoscale|October 8, 2016
Hydro-actuation of hybrid carbon nanotube yarn musclesXiaogang Gu, Qingxia Fan, Feng Yang, et al.
Oncotarget|April 15, 2017
Insulin growth factor binding protein 2 mediates the progression of lymphangioleiomyomatosisXiangke Li, Xiaolei Liu, Linda Zhang, et al.
Thoracic Cancer|March 24, 2021
SHR-1316, an anti-PD-L1 antibody, plus chemotherapy as the first-line treatment for advanced esophageal squamous cell carcinoma: A multicentre, phase 2 studyLan Mu, Yan Song, Kuaile Zhao, et al.
Chinese Medical Journal|January 8, 2015
Prognostic significance of tumor-infiltrating CD8⁺ or CD3⁺ T lymphocytes and interleukin-2 expression in radically resected non-small cell lung cancerChuntao Tian, Shixin Lu, Qingxia Fan, et al.
Journal of Cellular and Molecular Medicine|July 6, 2019
miR-516a-3p inhibits breast cancer cell growth and EMT by blocking the Pygo2/Wnt signalling pathwayYanyan Chi, Feng Wang, Tengfei Zhang, et al.
Pageof 11

Showing results (41-50 of 107) with videos related to

Sort By:
Pageof 11
Oncology Reports|September 2, 2014
Assessment of insulin-like growth factor 1 receptor as an oncogene in esophageal squamous cell carcinoma and its potential implication in chemotherapyWang Ma, Tengfei Zhang, Jian Pan, et al.
Cell Biochemistry and Biophysics|February 26, 2011
Antitumor activity of a combination of rAd2p53 adenoviral gene therapy and radiotherapy in esophageal carcinomaPing Lu, Xiaoyu Yang, Yanmei Huang, et al.
International Journal of Oncology|May 17, 2018
MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathwayYan Zhao, Ke Ma, Shujun Yang, et al.
Biochemical and Biophysical Research Communications|June 27, 2019
Retraction notice to "miR-4295 promotes cell proliferation and invasion in anaplastic thyroid carcinoma via CDKN1A" [Biochem. Biophys. Res. Commun. 464/4 (2015) 1309-1313]Mingchen Shao, Yiwei Geng, Peng Lu, et al.
Biochemical and Biophysical Research Communications|August 2, 2015
miR-4295 promotes cell proliferation and invasion in anaplastic thyroid carcinoma via CDKN1AMingchen Shao, Yiwei Geng, Peng Lu, et al.
Nanoscale|October 8, 2016
Hydro-actuation of hybrid carbon nanotube yarn musclesXiaogang Gu, Qingxia Fan, Feng Yang, et al.
Oncotarget|April 15, 2017
Insulin growth factor binding protein 2 mediates the progression of lymphangioleiomyomatosisXiangke Li, Xiaolei Liu, Linda Zhang, et al.
Thoracic Cancer|March 24, 2021
SHR-1316, an anti-PD-L1 antibody, plus chemotherapy as the first-line treatment for advanced esophageal squamous cell carcinoma: A multicentre, phase 2 studyLan Mu, Yan Song, Kuaile Zhao, et al.
Chinese Medical Journal|January 8, 2015
Prognostic significance of tumor-infiltrating CD8⁺ or CD3⁺ T lymphocytes and interleukin-2 expression in radically resected non-small cell lung cancerChuntao Tian, Shixin Lu, Qingxia Fan, et al.
Journal of Cellular and Molecular Medicine|July 6, 2019
miR-516a-3p inhibits breast cancer cell growth and EMT by blocking the Pygo2/Wnt signalling pathwayYanyan Chi, Feng Wang, Tengfei Zhang, et al.
Pageof 11